Antibodies

09 Jun 2007 Regeneron submits biologics license application To US FDA for IL-1 Tap (Rilonacept) for treatment of CAPS
08 Jun 2007 Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
08 Jun 2007 Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
07 Jun 2007 Actemra: New data confirms significant improvement of disease signs and symptoms in patients with rheumatoid arthritis
07 Jun 2007 Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
06 Jun 2007 Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
06 Jun 2007 Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
06 Jun 2007 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
05 Jun 2007 Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin
05 Jun 2007 ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
04 Jun 2007 Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Survival Outcomes, Pfizer Says
04 Jun 2007 Genentech Provides Update on Pipeline Agents at The American Society of Clinical Oncology Meeting
04 Jun 2007 Genmab's HuMax-EGFr shows broad potential in cancer treatment
03 Jun 2007 Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients with Previously Untreated Advanced Kidney Cancer
03 Jun 2007 Results of VEGF trap (aflibercept) highlighted at ASCO 2007 annual meeting
01 Jun 2007 Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma
01 Jun 2007 Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
31 May 2007 BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
31 May 2007 Human Genome Sciences and GlaxoSmithKline initiate second phase 3 clinical trial of LymphoStat-B(R) in systemic lupus erythematosus
26 May 2007 Amgen to Appeal CHMP Opinion on Vectibix(TM) (Panitumumab)
25 May 2007 Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
25 May 2007 MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
25 May 2007 Viventia Biotech Inc. Reports Final Vicinium(TM) Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting
24 May 2007 Morphotek Receives Protocol Approval from German Regulatory Authority for Phase II Trial Site Selections in Heidelberg and Frankfurt
23 May 2007 Peptech enters Phase I clinical trial of PN0621

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top